Non-Vaccine mRNA Therapeutics To Earn $2 Billion By 2028
A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from five marketed messenger RNA...
Study Bringing Personalised Immunotherapy Therapies Closer
In an effort to advance personalised cancer treatment, researchers have shown that biomarkers alone cannot predict which patients will benefit most from immunotherapy.
Clinicians should...
Detecting Traces of β-Lactam Antibiotics Using UHPLC-MS-MS
The identification and detection of the β-lactams cephapirin and ceftiofur in cleaning solutions of the production reactors have been validated using ultra-performance liquid chromatography...
Leprosy-Causing Bacteria May Be Able To Regenerate Livers
Researchers have made a ground-breaking revelation: the parasites that cause leprosy can rewire cells to enlarge the liver.
According to the most recent study, it...
Nasal Vaccination Improves COVID-19 Protection In Australia
Researchers from Australia's Centenary Institute and the University of Sydney have created a novel nasal vaccination system that promotes strong lung resistance and tolerance...
Kidney Cancer UK Gains Breakthrough NICE Clinical Funding
Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and...
Oxford Researchers Uncover The Root Behind Type 2 Diabetes
The root cause of type 2 diabetes has been clarified by a new study, which shows that elevated blood glucose alters the metabolism of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...